Boston University
High-fidelity detection of G protein activity with complementary optical biosensor platforms
Abstract
dc:description.abstractG-protein-coupled receptors (GPCRs) are signaling proteins that regulate a plethora of biological processes, ranging from cognition to regulation of hormone responses. They are also the largest family of druggable targets encoded in the human genome. These receptors transduce extracellular stimuli into intracellular signaling cascades predominantly by activating heterotrimeric G proteins (Gαβγ). To gain functional insights into this quintessential transduction mechanism, or to develop drugs targeting GPCRs, the scientific community must rely on appropriate tools to assay GPCR-G protein activity. Yet, many of the existing technologies have limitations that severely hinder progress, including the reliance on indirect approaches to determine activity, which distort the fidelity of the readout, or the inability to implement them in physiologically-relevant cell types expressing endogenous GPCRs and/or G proteins. This results in the lack of methods to characterize the nuanced nature of endogenous GPCR-G protein signaling with sufficient fidelity, which contributes to a pervasive lack of translation of observations made in vitro into relevant progress in vivo. Here, we describe the development and implementation of two complementary platforms of biosensors that can directly monitor the activation of G proteins by endogenous GPCRs with high fidelity in a wide range of physiologically-relevant cell systems, including primary cultures of neurons, cardiovascular cells, or lung cells. The first biosensor platform, called ONE vector G protein optical (ONE-GO) biosensors, consists of a collection of genetic constructs that can be easily implemented in a variety of cellular models expressing endogenous GPCRs, yet requiring expression of small amounts of exogenous G proteins. The second biosensor platform consists of a suite of transgenic mice for the conditional expression of biosensors named Biosensor with glutamic acid-arginine/lysine (ER/K) linker and Yellow Fluorescent Protein (BERKY), which allows detection of activation of endogenous G proteins by endogenous GPCRs in virtually any mouse cell type amenable to primary cell culture. By leveraging these two biosensor platforms, we found that a prevalent feature of endogenous GPCR signaling is context-dependence i.e., it differs depending on cell type (e.g., endothelial cells vs. neurons) or status (e.g., upon fibrotic transformation or variation of the substrate stiffness). These biosensor platforms also allow carrying out pharmacological profiling experiments, like defining the multiple GPCR targets for different antipsychotic drugs, and revealing fundamental aspects of the molecular basis of GPCR-G protein signal transduction, like defining the active G protein species that determine signal specificity under endogenous conditions. In summary, the technologies introduced here could transform the large field of GPCR-G protein signaling by making qualitative advances in something as fundamental as recording the activity of this mechanism of cellular transduction with high fidelity and versatility of implementation across physiologically relevant systems.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy
- Level thesis:degree_level
- doctoral
- Discipline thesis:degree_discipline
- Biochemistry
- Grantor
- Boston University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Janicot, Remi
- Advisor dc:contributor.advisor
-
- Garcia-Marcos, Mikel
Subjects
dc:subject × 3Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/52130